Carocellbio
1 known investors
Find your way into Carocellbio
541 people in our graph share verified history with the Carocellbio team — schools, employers, funds. One of them is your warm intro.
Sam Blackmanunlockedknows Ashley George · together at GlaxoSmithKline (overlapped)
×4knows the team · via GlaxoSmithKline
knows the team · via The University of Edinburgh
×2knows the team · via UCL
×4knows the team · via University of St Andrews
Carocell Bio develops peptide-based anti-inflammatory therapeutics, including its lead peptide JEL0305, that inhibit the intracellular MAPK (p38) inflammatory pathway and are combined with a nanoparticle delivery technology for topical application to the skin. It targets inflammatory conditions such as eczema (atopic dermatitis) and inflammation-related skin ageing.
Founders & leadership
MD
Mike DaviesinCEO & FounderMike Davies is CEO and founder of Carocell Bio, which develops peptide-based therapeutics combined with nanoparticle delivery technology for inflammatory skin conditions including atopic dermatitis.
AG
Ashley GeorgeinInterim Chairman & Financial DirectorAshley George brings over two decades of global leadership experience across pharmaceuticals, consumer healthcare, and venture-backed startups, including Board-level roles and financial management positions. She holds a visiting professor appointment at University College London and has led digital transformation initiatives and strategic business development across international teams.
Investors · 1
Frequently asked questions
- What does Carocellbio do?
- Carocell Bio develops peptide-based anti-inflammatory therapeutics, including its lead peptide JEL0305, that inhibit the intracellular MAPK (p38) inflammatory pathway and are combined with a nanoparticle delivery technology for topical application to the skin. It targets inflammatory conditions such as eczema (atopic dermatitis) and inflammation-related skin ageing.
- Who founded Carocellbio?
- Carocellbio was founded by Mike Davies.
- Who are Carocellbio's investors?
- Carocellbio's investors include Deepbridge Capital.